Impacto familiar de la severidad de la dermatitis atópica en menores de 12 años
DOI:
https://doi.org/10.29166/ciencias_medicas.v42i2.1500Keywords:
atopic dermatitis, family impact, family functionality, eczema, SCO-RAD, DFI Finley, family APGARAbstract
Context: Atopic dermatitis is a disease of unknown etiology, with genetic predisposition and participation of environmental factors. More than 80% of affected children debu-tan before 5 years of age. There are no reports in the country that demonstrate the relationship between the severity of the disease and the family impact generated by it.
Objective: to determine the degree of family involvement in children diagnosed with atopic dermatitis who attended the outpatient clinic of the “Skin Center” and its relationship with the severity of the disease.
Design: cross-sectional analytical epidemiological study of period.Methods and subjects: the study was conducted in children under 12 years of age who attended the “Skin Center” medical consultation, with a diagnosis of atopic dermatitis from July to November 2015. Simple random sampling was used. for infinite universe with qualitative objective.
MAIN MEASUREMENTS: the severity of atopic dermatitis was classified according to the SCORAD scale. The family impact was determined with the family impact questionnaire of DFI dermatitis and family functionality with the family APGAR scale. The associations between the variables studied were summarized
with Odds Prevalence Ratio (OR) and the corresponding 95% confidence intervals (95% CI) obtained by binomial distribution. For the hypothesis test, the Pearson correlation coefficient was calculated.
Results: the study revealed that of the 145 participants, 34 (23.45%) presented mild atopic dermatitis, 94 (64.83%) moderate and 17 (11.72%) severe. It was found that in more than half of the families investigated (57.24%) the family impact of the disease was moderate, 33.1% mild and 9.66% severe. By relating the variables, it was shown that the degree of family involvement is proportional to the severity of the dermatitis, statistically significant (p value = <0.01). The most affected family sphere was the economic one, showing the relationship between worsening of the table and the increase in the expenses derived from the treatment (OR: 5.5, 95% CI: 2.4-12.6).
Conclusion: the severity of atopic dermatitis was significantly related to the level of family impact perceived by the caregiver
Downloads
Metrics
References
Hanifin JM. Diagnosis features of atopic dermatitis. Acta Dermato-Venereológica 1980; :44-47.
Leung D, et al. Atopic Dermatitis en Fitzpatrick T. Dermatology in general medicine. New York:McGraw Hill, 1993.
Leung D, EichenfIeld L, Boguniewicz M. Fitzpatrick T. Dermatology in general medicine. New York:McGraw Hill, 2008.
Irvine AD, McLean WH. Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. Journal of Investigative Dermatology 2006; :1200-1202.
Bieber T. Atopic dermatitis. New England Journal of Medicine2008; :1483-1494.
Schmitt J, Langan S, Williams HC. What are the best outcome measurements for atopic eczema? A systematic review. Journal of Allergy and Clinical Immunology 2007; :1389-1398.
Schmitt J, Langan S, Deckert S, Svensson A, von Kobyletzki L, Thomas K, Spuls P. Assessment of clinical signs of atopic dermatitis: a systematic review and recommendation. Harmonising outcome measure for atopic dermatitis (HOME) initiative. Journal of Allergy and Clinical Immunology 2013; :1337-1347.
Ben-Gashir MA, Seed PT, Hay RJ. Are quality of family life and disease severity related in childhood atopic dermatitis? Journal of the European Academy of Dermatology and Venereology 2002; :455-462.
Dodington SR, et al. The Dermatitis Family Impact questionnaire: a review of its measurement properties and clinical application. British Journal of Dermatology 2013; :31-46.
Poot F, et al. A case-control study on family dysfunction in patient with alopecia aerata, psoriasis and atopic dermatitis. Acta Dermato-Venereológica 2011; :415-421.
Im YJ, et al. Parenting and relationship characteristics in mothers with their children having atopic disease. Journal for Child Health Care 2014; :215-229.
Salamanca A. Factores biológicos y psicológicos de la dermatitis atópica. Psychologia. Avances de la disciplina 2011; :47-58.
Balkrishnan R, et al. Disease severity and associated family impact in childhood atopic dermatitis. Archives of Disease in Childhood 2003; :423-427.
Möhrenschlager M, et al. The course of eczema in children aged 5–7 years and its relation to atopy: differences between boys and girls. British Journal of Dermatology 2006; :505-513.
Sehgal VN, et al. Atopic dermatitis: a cross-sectional (descriptive) study of 100 cases. Indian Journal of Dermatology 2015; :519.
Getachew Kelbore A, et al. Magnitude and associated factors of atopic dermatitis among children in Ayder referral hospital, Mekelle-Ethiopia. BioMed Central 2015; :15.
Blanco Quirós A, et al. Factores de riesgo y prevalencia familiar de la dermatitis atópica en España (estudio ELIHO). Anales de Pediatría 2005; :480-488.
Solé D, Mallol J, Wandalsen GF, Aguirre V. Prevalence of symptoms of eczema in Latin America: results of the international study of asthma and allergies in childhood (ISAAC) Phase 3. Journal of Investigational Allergology and Clinical Inmunology 2010; :311-323.
Taylor-Robinson DC, et al. Do early life exposures explain why more advantaged children get eczema? Findings from the UK Millennium Cohort Study. British Journal of Medicine 2015;
DaVeiga SP. Epidemiology of atopic dermatitis: a review. Allergy and Asthma Proceedings: The Official Journal of Regional and State Allergy Societies 2012; :221-234.
Emerson RM, Williams HC, Allen BR. Severity distribution of atopic dermatitis in the community and its relationship to secondary referral. British Journal of Dermatology 1998; :73-76.
Beattie PE, Lewis-Jones MS. An audit of the impact of a consultation with a pediatric dermatology team on quality of life in infants with atopic eczema and their families: further validation of the Infants Dermatitis Quality of Life Index and Dermatitis Family Impact score. British Journal of Medicine 2006; :1249-1255.
Handa S, Jain N, Narang T. Cost of care of atopic dermatitis in India. Indian Journal of Dermatology Veneorology and Leprology 2015; :213.
Aziah MS, et al. Childhood atopic dermatitis: a measurement of quality of life and family impact. The Medical Journal of Malaysia 2002; :329-339.
Chernyshov PV, et al. An international multicenter study on quality of life and family quality of life in children with atopic dermatitis. Indian Journal of Dermatology, Veneorology and Leprology 2013; :52-58.
Beattie PE, Lewis-Jones MS. A pilot study on the use of wet wraps in infants with moderate atopic eczema. Clinical and Experimental Dermatology 2004; :348-353.
